KFDA approves additional indications of Zocor

The Korea Food and Drug Administration announced it approved the additional indications of MSD Korea's lipid-lowering agent Zocor 40mg (simvastatin):

For patients with coronary heart disease (CHD) and high cholesterol, Zocor is indicated as an addition to diet to reduce the risk of death by reducing coronary death; to reduce the risk of heart attack; to reduce the risk for undergoing cardiac...